Amelioration of type 1 diabetes following treatment of non-obese diabetic mice with INGAP and lisofylline-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Amelioration of type 1 diabetes following treatment of non-obese diabetic mice with INGAP and lisofylline

Published:2012 Issue:02 Volume:02 Page:251-257
ISSN:2160-5831
Container-title:Journal of Diabetes Mellitus
language:
Short-container-title:JDM

Author:

A. Tersey Sarah,D. Carter Jeffery,Rosenberg Lawrence,A. Taylor-Fishwick David,G. Mirmira Raghavendra,L. Nadler Jerry

Publisher

Scientific Research Publishing, Inc.

Subject

General Medicine

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting IL-12 family cytokines: A potential strategy for type 1 and type 2 diabetes mellitus;Biomedicine & Pharmacotherapy;2024-01

2. Lisofylline mitigates cardiac inflammation in a mouse model of obesity through improving insulin secretion and activating cardiac AMPK signaling pathway;Cytokine;2021-02

3. Scalable Self-Assembling Micellar System for Enhanced Oral Bioavailability and Efficacy of Lisofylline for Treatment of Type-I Diabetes;Molecular Pharmaceutics;2019-10-24

4. Inflammatory Pathways Linked to β Cell Demise in Diabetes;Islets of Langerhans;2014-04-17

5. Inflammatory Pathways Linked to Beta Cell Demise in Diabetes;Islets of Langerhans, 2. ed.;2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP